Treace Medical Concepts Inc
Research Treace Medical Concepts Inc (TMCI) on Bullrun: market cap USD 262.90M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTMCI
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 262.90M
- Financial periodQ3 2026
- RevenueUSD 48.25M
- Net income-USD 12.57M
- Free cash flow-USD 5.43M
- Gross margin79.5%
Valuation Snapshot
latest market cap is USD 262.90M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 212.69M | -USD 59.00M | -USD 29.49M | 79.8% | -0.93 | USD 10.71M | USD 57.33M | USD 87.33M |
| FY2024 | USD 209.36M | -USD 55.74M | -USD 48.76M | 80.4% | -0.9 | USD 11.35M | USD 53.31M | USD 112.89M |
| FY2023 | USD 187.12M | -USD 50.00M | -USD 46.03M | 81.2% | -0.81 | USD 12.98M | USD 53.01M | USD 137.94M |
| FY2022 | USD 141.84M | -USD 43.00M | -USD 45.49M | 82.0% | -0.77 | USD 19.47M | USD 52.71M | USD 60.53M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-11-06 | USD 262.90M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 156.47M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 463.97M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 786.37M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 1.28B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.01B | n/a | n/a | n/a |
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes;
ETFs that hold Treace Medical Concepts Inc
US-listed ETFs
Treace Medical Concepts Inc is held by 13 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard Morningstar Total Stock Market ETF (VTI) | <0.01% | 0.03% |
| iShares Core S&P Total U.S. Stock Market ETF (ITOT) | <0.01% | 0.03% |
| Vanguard Russell 2000 Index Fund ETF Shares (VTWO) | <0.01% | 0.06% |
| Schwab U.S. Small-Cap ETF (SCHA) | <0.01% | 0.03% |
| Vanguard Extended Market Index Fund ETF Shares (VXF) | <0.01% | 0.05% |
| Vanguard Health Care Index Fund ETF Shares (VHT) | <0.01% | 0.09% |
| U.S. Small Cap Portfolio-ETF Class Shares (DFAS) | <0.01% | 0.26% |
| iShares Micro-Cap ETF (IWC) | 0.04% | 0.60% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Treace Medical Concepts Inc's market cap?
Treace Medical Concepts Inc's market capitalization is USD 262.90M.
What does Treace Medical Concepts Inc do?
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States.